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Summary
Background.  —  Insufﬁcient  correction  of  mechanical  dyssynchrony  is  a  cause  of  non-response  toresynchronization
therapy;
Mechanical
cardiac resynchronization  therapy  (CRT).
Aims.  —  To  determine  if  CRT  delivery  could  be  optimized  during  the  implantation  procedure  by
choosing the  number  and  location  of  pacing  sites  using  echocardiography  guidance.dyssynchrony Methods. —  In  patients  with  a  QRS  ≥  150  ms  or  a  QRS  <  150  ms  and  criteria  for  mechanical  dyssyn-
chrony, the  objective  of  the  implantation  procedure  was  to  shorten  the  left  pre-ejection  interval
Abbreviations: CRT, Cardiac resynchronization therapy; DDD, Dual-chamber; IVMD, Interventricular mechanical delay; LPEI, Left pre-
ejection interval; LSWMD, Lateral-to-septal wall motion delay; LV, Left ventricular; LVEF, Left ventricular ejection fraction; LVET, Left
ventricular ejection time; LVFT, Left ventricular ﬁlling time; MVRS/LAS, Mitral valve regurgitant surface divided by left atrial surface; NYHA,
New York Heart Association; RPEI, Right pre-ejection interval; RV, Right ventricular; TDS, Total duration of systole.
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(LPEI),  measured  online,  by  at  least  10  ms  compared  with  standard  biventricular  conﬁguration,
by moving  the  right  ventricular  (RV)  lead  at  different  locations  and,  if  necessary,  by  adding  a
second RV  lead.
Results.  —  Ninety-one  patients  (70  men;  mean  age  73  ±  10  years;  left  ventricular  [LV]  ejection
fraction 29  ±  10%)  were  included.  The  ﬁnal  pacing  conﬁguration  was  standard  biventricular
in 15  (17%)  patients,  optimized  biventricular  in  22  (24%)  and  triple-site  ventricular  in  54
(59%). LPEI  was  shortened  by  ≥  10  ms  compared  with  standard  biventricular  stimulation  in
73 (80%)  patients.  Compared  with  standard  biventricular  pacing,  the  ﬁnal  optimized  pacing
conﬁguration  improved  global  intraventricular  synchrony  (decreasing  LPEI  from  158  ±  36  ms  to
134 ±  29  ms;  P  <  0.001),  LV  systolic  efﬁciency  (decreasing  LPEI/LV  ejection  time  from  0.58  ±  0.18
to 0.46  ±  0.13;  P  <  0.001)  and  LV  ﬁlling  (increasing  LV  ﬁlling  time/RR  from  44  ±  8%  to  47  ±  7%;
P <  0.001)  and  decreased  mitral  valve  regurgitation.
Conclusion.  —  Intraoperative  echocardiography-guided  placement  of  RV  lead(s)  during  CRT
implantation  is  feasible  and  acutely  improves  LV  synchrony  compared  with  standard  biven-
tricular stimulation.
©  2014  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Contexte.  —  La  correction  insufﬁsante  de  la  désynchronisation  mécanique  est  une  cause  de
non-réponse  à  la  thérapie  de  resynchronisation  cardiaque  (CRT).
Objectif.  —  Déterminer  si  la  CRT  est  optimisable  durant  l’implantation  en  faisant  varier  le
nombre et  le  site  de  stimulation  par  guidage  échocardiographique.
Méthodes.  —  Chez  des  patients  avec  un  QRS  ≥  150  ms  ou  avec  un  QRS  <  150  ms  et  une  désyn-
chronisation  mécanique,  l’objectif  de  la  procédure  d’implantation  était  de  raccourcir  le  délai
pré-éjectionnel  gauche  (LPEI),  mesuré  en  temps  réel,  de  ≥  10  ms  par  rapport  à  la  conﬁguration
biventriculaire  standard,  en  déplac¸ant  la  sonde  ventriculaire  droite  (VD)  et  si  nécessaire  en
ajoutant une  seconde  sonde  VD.
Résultats.  —  Quatre-vingt  onze  patients  (70  hommes  ;  âge  73  ±  10  ans  ;  FEVG  29  ±  10  %)  ont  été
inclus. La  conﬁguration  de  stimulation  ﬁnale  était  biventriculaire  standard  chez  15  (17  %)
patients, biventriculaire  optimisé  chez  22  (24  %)  et  triple-site  ventriculaire  chez  54  (59  %).
L’objectif a  été  atteint  chez  73  (80  %)  patients.  Comparée  à  la  stimulation  biventriculaire
standard,  la  conﬁguration  de  stimulation  ﬁnale,  optimisée,  a  amélioré  la  synchronisation
intraventriculaire  globale  (LPEI  raccourci  de  158  ±  36  ms  à  134  ±  29  ms  ;  p  <  0,001),  l’efﬁcience
systolique  du  ventricule  gauche  (VG)  (LPEI/temps  d’éjection  VG  diminuant  de  0,58  ±  0,18  à
0,46 ±  0,13  ;  p  <  0,001),  le  remplissage  VG  (remplissage  VG/RR  augmentant  de  44  ±  8  %  à
47 ±  7  %  ;  p  <  0,001)  et  a  diminué  l’insufﬁsance  mitrale.
Conclusion.  —  Le  guidage  de  la  mise  en  place  de  la  (des)  sonde(s)  VD  durant  l’implantation  de
la CRT  par  une  échocardiographique  peropératoire  est  faisable  et  améliore  en  aigu  la  synchro-
nisation VG  comparé  à  la  stimulation  biventriculaire  standard.
© 2014  Elsevier  Masson  SAS.  Tous  droits  réservés.
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introduction
ardiac  resynchronization  therapy  (CRT)  is  an  effective
reatment  for  patients  with  symptomatic  heart  failure,
ow  left  ventricular  ejection  fraction  (LVEF)  and  a  wide
RS  [1].  In  controlled  clinical  trials,  at  least  one  third
f  patients  do  not  respond  clinically  to  CRT  [2—6].  The
auses  of  non-response  are  various,  including  improper
atient  selection  and  therapy  delivery.  Patient  selection
s  presently  based  on  QRS  morphology  and  QRS  width  [1],
ut  this  approach  could  be  too  simplistic,  as  some  wide
RS  patients  do  not  take  advantage  of  CRT.  Additionally,
arrow  QRS  patients  do  not  seem  to  beneﬁt  from  standard
mplantation  techniques,  as  demonstrated  in  EchoCRT  trial
c
w
o
r7],  and  alternative  procedures  are  needed  to  address  this
articular  patient  population.
From  a  global  mechanical  perspective,  the  effect  of
esynchronization  may  be  viewed  as  improvement  of  left
entricular  (LV)  efﬁciency  by  shortening  the  total  systole
uration  without  shortening  the  LV  ejection  time  (LVET)  [8],
ith  a  consequent  increase  in  LV  ﬁlling  time  (LVFT).  In  a
revious  study  in  patients  with  a  QRS  <  150  ms,  we  showed
hat  selecting  patients  with  pre-existing  left  atrioventric-
lar,  interventricular  and/or  temporal  but  not  spatial  left
ntraventricular  dyssynchrony  was  associated  with  improved
linical  response  to  CRT  [9], irrespective  of  baseline  QRS
idth  and  QRS  change  after  CRT.  However,  and  despite  the
ptimized  selection  process,  effective  and/or  optimal  cor-
ection  of  mechanical  dyssynchrony  could  not  be  achieved
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Figure 1. Inter- and intraventricular dyssynchrony. Simultaneous
display of the electrocardiogram, aortic and pulmonary (Pulm.)
ejection ﬂows, left ventricular ﬁlling and left lateral wall contrac-
tion. Diastolic contraction is the duration of persistent contraction
after closure of the aortic valve (AoV). Overlap is the duration of
the persistent contraction after opening of the mitral valve (MV).
IVMD: interventricular mechanical delay (LPEI—RPEI); LPEI: left pre-
ejection interval; LVET: left ventricular ejection time; RPEI: right
pre-ejection interval; TDS: total duration of systole.
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in  all  patients  using  a  standard  biventricular  pacing  conﬁg-
uration.
Therefore,  we  hypothesized  that  the  quality  of  resyn-
chronization  might  be  inﬂuenced  by  the  number  and  location
of  pacing  sites,  which  are  difﬁcult  to  anticipate  before  the
implantation  procedure.
In  this  study,  we  selected  candidates  for  CRT  and
attempted  to  acutely  optimize  CRT  delivery  during  the
procedure,  with  echocardiographically  guided  mechanistic
evaluation  of  synchrony.  As  optimal  placement  of  the  LV
lead  is  challenging  and  as  both  ventricles  are  not  elec-
trically  independent,  we  deliberately  choose  to  optimize
therapy  delivery  by  moving  the  right  ventricular  (RV)  lead
at  different  locations  and,  if  necessary,  by  adding  a  sec-
ond  RV  lead.  The  objective  of  the  optimization  process
was  to  improve  LV  efﬁciency  and  to  decrease  the  left
pre-ejection  interval  (LPEI,  deﬁned  as  the  time  interval
between  the  onset  of  QRS  and  the  onset  of  LV  ejection)  as
much  as  possible  compared  with  a  standard  biventricular
conﬁguration.
Methods
Patient selection
Patients  were  included  in  this  prospective  observational
single-centre  study  if  they  had  New  York  Heart  Association
(NYHA)  class  II—IV  heart  failure  despite  optimal  medical
therapy,  an  LVEF  ≤  40%  and  either  a  QRS  ≥  150  ms  or  a
QRS  <  150  ms  with  criteria  for  mechanical  dyssynchrony  as
deﬁned  in  the  DESIRE  study  [9]:  atrioventricular  dyssyn-
chrony  was  deﬁned  as  an  LVFT/RR  interval  ratio  <  40%;
interventricular  dyssynchrony  was  deﬁned  as  an  inter-
ventricular  mechanical  delay  (IVMD,  calculated  as  the
difference  between  LPEI  and  right  pre-ejection  interval
[RPEI])  >  40  ms;  global  intraventricular  dyssynchrony  was
deﬁned  as  an  LPEI  >  140  ms;  local  (lateral  or  septal)  temporal
intraventricular  dyssynchrony  was  deﬁned  as  the  presence
of  a  ‘diastolic’  contraction  of  the  LV  lateral  wall  or  septum
occurring  after  the  aortic  valve  closure,  sometimes  with  an
overlap  beyond  opening  of  the  mitral  valve  (Fig.  1).
Ninety-one  patients  were  enrolled,  including  46  patients
undergoing  a  ﬁrst  CRT  device  implantation,  31  patients
upgraded  from  a  conventional  dual-chamber  (DDD)  pace-
maker  to  CRT  and  14  patients  reoperated  on  for  clinical
non-response  (persistent  signs  of  heart  failure)  after  pre-
vious  CRT  implantation.
This  study  was  approved  by  our  institution’s  ethics  com-
mittee.  All  patients  granted  their  informed  consent  to
participate.
Echocardiographical measurements
Intraoperative  transthoracic  echocardiography  was  per-
formed  using  the  four-chamber  apical  view  (Vivid  7;  General
Electric  Healthcare,  Milwaukee,  WI,  USA).  Acquisitions  were
done  in  baseline  condition  (i.e.  without  pacing  in  patients
undergoing  their  ﬁrst  CRT  device  implantation,  standard
DDD  pacing  in  patients  upgraded  from  DDD  pacing  to  CRT
and  biventricular  pacing  in  patients  reoperated  on  after
previous  CRT  implantation)  then  during  RV,  LV  and  biven-
d
mricular  pacing  conﬁgurations  in  random  order,  in  VDD  mode
or  patients  in  sinus  rhythm  and  in  VVI  mode  for  patients
n  atrial  ﬁbrillation.  Aortic  ejection  ﬂow,  transmitral  ﬂow,
itral  valve  regurgitation  area  and  tissue  Doppler  images
f  the  LV  lateral  wall  and  septum  were  recorded.  Due  to
he  surgical  draping  acquisitions  for  RPEI  measurement  were
nly  recorded  at  baseline  and  with  the  ﬁnal  conﬁgura-
ion.  LPEI  was  measured  online  and  was  used  to  guide  the
mplantation  procedure.  All  other  time  intervals  were  mea-
ured  ofﬂine.  In  addition  to  the  time  intervals  described
bove,  QRS-E  (onset  of  QRS  to  onset  of  mitral  E  wave),
VET  (opening  to  closure  of  the  aortic  valve),  total  dura-
ion  of  the  systole  (TDS,  equal  to  the  sum  of  LPEI  plus  LVET)
nd  lateral-to-septal  wall  motion  delay  (LSWMD)  by  tissue
oppler  imaging  were  measured.  The  ratio  between  pre-
jection  and  ejection  durations  (LPEI/LVET)  was  calculated.
itral  valve  regurgitation  was  evaluated  as  the  maximal  sur-
ace  of  the  regurgitant  ﬂow  divided  by  the  left  atrial  surface
MVRS/LAS).
There  was  no  interobserver  variability  because  all  the
easurements  were  taken  by  a single  experienced  echocar-
iographer.  Intraobserver  variability  was  minimized  by  a
ean  of  3—5  measures  per  acquisition.
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Figure 2. Intraoperative echocardiographic guidance of implantation procedure. Online measurement of left pre-ejection interval (A)
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chocardiography-guided implantation
rocedure
aseline  LPEI  was  measured  at  admission  in  the  operating
oom  in  all  patients  (Fig.  2A).  The  predeﬁned  objective  of
his  patient-tailored  procedure  was  to  shorten  the  LPEI  by
t  least  10  ms  compared  with  standard  biventricular  conﬁg-
ration.  This  value  was  determined  based  on  ﬁndings  from
he  PROSPECT  trial,  in  which  the  intraobserver  and  interob-
erver  coefﬁcients  of  variation  of  LPEI  measurements  were
.7%  and  6.5%,  respectively  [10].  As  a  prolonged  LPEI  is
eﬁned  as  ≥140  ms,  we  hypothesized  that  140  ms  ×  6.5%
i.e.  9.1  ms)  should  be  the  minimal  change  not  related  to
ny  intra-  or  interobserver  variability;  10  ms  is  a  convenient
pproximation  of  this  delay.
In  patients  undergoing  a  ﬁrst  CRT  implantation,  RV  and
V  leads  were  implanted  in  usual  positions  according  to
perator’s  habits  (RV  lead  either  at  the  apex  or  septum,
V  lead  classically  in  a  lateral  or  posterolateral  vein).
fter  recording  the  echocardiographical  variables  in  this
rst  conﬁguration,  hereafter  termed  ‘standard  biventricular
timulation’  (Fig.  2B),  the  RV  lead  was  moved  to  a dis-
ant  second  position  and  new  echocardiographical  data  were
cquired.  If  LPEI  reduction  was  satisfactory  in  the  ﬁrst  posi-
ion  and  not  in  the  second  position,  standard  biventricular
timulation  was  selected  and  the  procedure  was  stopped.
f  both  RV  lead  positions  did  not  achieve  sufﬁcient  LPEI
o
dular lead to another location and (C) during triple-site ventricular
g an improvement in global intraventricular dyssynchrony.
eduction  and/or  if  the  second  was  better  than  the  ﬁrst,
he  RV  lead  was  further  moved  until  ‘optimized  biventric-
lar  stimulation’  was  obtained.  If  sufﬁcient  LPEI  reduction
ould  still  not  be  achieved  with  a  single  RV  lead,  a  second
V  lead  was  inserted  and  the  best  ‘triple-site  ventricular
onﬁguration’  was  selected  (Fig.  2C).  In  case  of  triple-
ite  conﬁguration,  a  Y-bifurcated  adapter  (2872;  Medtronic,
inneapolis,  MN,  USA)  was  used  to  connect  the  LV  lead  and
 RV  lead  (the  pacing  lead  in  case  of  a  CRT  deﬁbrillator  or
he  best  RV  lead  in  case  of  a  CRT  pacemaker)  to  the  LV  port
f  the  CRT  device  (Fig.  3).  The  deﬁbrillation  lead  in  case
f  a  CRT  deﬁbrillator  or  the  other  RV  lead  in  case  of  CRT
acemaker  was  connected  alone  to  the  RV  channel.
In  patients  upgraded  from  a  conventional  dual-chamber
acemaker,  the  echocardiographical  variables  were  recor-
ed  after  implantation  of  the  LV  lead.  If  this  standard
iventricular  conﬁguration  was  not  optimal,  a  new  RV
ead  was  inserted  and  the  procedure  was  completed  to
ither  optimized  biventricular  stimulation  or  triple-site
entricular  stimulation.
In  patients  reoperated  on  after  a  ﬁrst  CRT  implant,  a  sec-
nd  RV  lead  was  systematically  implanted  at  a  site  distant
rom  the  original  RV  lead  and  moved  until  the  best  opti-
ized  biventricular  or  triple-site  ventricular  stimulation  was
btained.
The  procedure  was  stopped  after  2  hours  of  total  proce-
ural  time  if  sufﬁcient  LPEI  reduction  was  still  not  obtained.
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Table  1  Final  pacing  conﬁguration.
Final  pacing  conﬁguration
Standard
biventricular
Optimized
biventricular
Triple-site
ventricular
First  implantation  (n  =  46) 5 16  25
Upgrade  from  dual-chamber  pacemaker  (n  =  31)  10  6  15
Biventricular  reoperation  (n  =  14)  0  0  14
5  (17
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Statistical analysis
Data  are  expressed  as  means  ±  standard  deviations.  A  paired
samples  t  test  was  applied  to  assess  the  differences  between
baseline  and  ﬁnal  measurements.  A  P  value  <  0.05  was
considered  statistically  signiﬁcant.  Statistical  analysis  was
performed  using  SPSS  software,  version  17.0  (SPSS  Inc.,
Chicago,  IL,  USA).
Results
Patient population
Ninety-one  patients  (70  men;  21  women)  with  a  mean  age  of
73  ±  10  years  were  included.  Thirty-two  (35%)  patients  had
been  hospitalized  for  congestive  heart  failure  in  the  pre-
vious  6  months.  Twenty-three  (25%)  patients  were  in  NYHA
class  II,  57  (63%)  in  class  III  and  11  (12%)  in  class  IV  at  the
time  of  the  procedure.  Heart  failure  was  due  to  ischaemic
cardiomyopathy  in  41  (45%)  patients  and  dilated  cardiomy-
opathy  in  50  (55%)  patients.  Sixteen  (18%)  patients  had
diabetes  and  37  (41%)  had  a  history  of  hypertension.  Perma-
nent  atrial  ﬁbrillation  was  present  in  22  (24%)  patients.  Mean
LVEF  was  29  ±  10%  and  mean  baseline  LPEI  was  154  ±  40  ms.
Mean  QRS  width  was  165  ±  37  ms  (141  ±  31  ms  in  patients
undergoing  ﬁrst  CRT  device  implant,  193  ±  22  ms  in  patients
upgraded  from  a  conventional  DDD  pacemaker  to  CRT  and
184  ±  30  ms  in  patients  reoperated  on  after  a  previous
CRT).  Baseline  medical  therapy  included  beta-blockers  in  67
(74%)  patients,  an  angiotensin-converting  enzyme  inhibitor
or  an  angiotensin  receptor  blocker  in  80  (88%)  patients,
g
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Table  2  Evolution  of  left  ventricular  ejection  fraction,  QRS  w
LVEF  (%)  QRS  wid
Baseline  Final  P  Baseline
All  patients 29  ±  10  37  ±  12  <0.001  165  ±  37
First  implantation 27  ±  10 37  ±  14  <0.001  141  ±  31
Upgrade  from
dual-chamber
pacemaker
32 ±  9  40  ±  7  <0.001  193  ±  22
Biventricular
reoperation
25  ±  9  32  ±  12  0.03  184  ±  30
LVEF: left ventricular ejection fraction.%)  22  (24%)  54  (59%)
pironolactone  in  36  (40%)  patients  and  a loop  diuretic  in
0  (88%)  patients.
mplantation procedure
he  optimization  process  could  not  be  completed  in  three
atients  because  of  difﬁcult  manipulation  of  leads  in  a
arrow  costoclavicular  space.  There  were  two  periopera-
ive  complications:  one  pericardial  effusion  during  coronary
inus  cannulation;  and  one  pocket  haematoma  that  did  not
equire  evacuation.  The  initial  RV  lead  positioning  was  api-
al  in  45  patients  and  septal  in  46  patients.  Implantation
f  the  LV  lead  in  a  lateral  or  posterolateral  vein  was  suc-
essful  in  all  patients.  The  ﬁnal  pacing  conﬁguration  was
tandard  biventricular  in  15  (17%)  patients,  optimized  biven-
ricular  in  22  (24%)  and  triple-site  ventricular  in  54  (59%)
Table  1);  it  was  triple-site  ventricular  in  all  non-responders
ith  a  previously  implanted  CRT  device.  At  the  end  of  the
rocedure,  LVEF  increased  acutely  to  37  ±  12%  (P  <  0.001
ompared  with  baseline),  paced  QRS  width  shortened  to
48  ±  24  ms  (P  <  0.001  compared  with  baseline)  and  the  QRS
xis  shifted  rightward  to  13  ±  111◦ (P  =  0.007)  (Table  2).
mpact on mechanical dyssynchrony
PEI  was  shortened  by  ≥10  ms  compared  with  standard
iventricular  stimulation  in  73  (80%)  patients.  In  the  sub-
roup  of  15  patients  with  a  standard  biventricular  conﬁgu-
ation  as  the  ﬁnal  conﬁguration,  LPEI  was  reduced  by  ≥10  ms
ompared  with  baseline  in  12  patients.  LPEI  remained
nchanged  in  the  three  patients  in  whom  moving  the  original
idth  and  axis.
th  (ms)  QRS  axis  (◦)
 Final  P  Baseline  Final  P
 148  ±  24  <0.001  —30  ±  59  13  ±  111  0.007
 142  ±  20  0.95  —25  ±  53  18  ±  105  0.04
 149  ±  28  <0.001  —43  ±  50  —12  ±  120  0.28
 169  ±  20  0.07  —11  ±  104  69  ±  91  0.06
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Table  3  Echocardiographical  variables  of  dyssynchrony  according  to  pacing  conﬁguration.
LVFT/RR  (%)  QRS-E  (ms)  LPEI  (ms)  IVMD  (ms)  DC-Sept  (ms)  OL-Sept  (ms)
All  patients
Baseline  43  ±  8  522  ±  67  154  ±  40  43  ±  32  128  ±  96  61  ±  99
Standard  BiV  44  ±  8  510  ±  56  158  ±  36  ND  89  ±  91b 13  ±  92c
Final  conﬁguration  47  ±  7c,f 503  ±  55b,e 134  ±  29c,f 10  ±  29a 68  ±  96c —4  ±  104c
First  implantation
Baseline  42  ±  7  488  ±  62  135  ±  36  40  ±  33  114  ±  86  57  ±  95
Standard  BiV  43  ±  9  496  ±  53  158  ±  34c ND  91  ±  92  10  ±  83a
Final  conﬁguration  45  ±  7c,f 497  ±  58  133  ±  29f 6  ±  38  68  ±  72b —9  ±  81c
Upgrade  from  DDD  pacemaker
Baseline  44  ±  9 561  ±  55 170  ±  36 43  ±  31  145  ±  99  61  ±  98
Standard  BiV  47  ±  7  506  ±  54c 146  ±  37c 64  ±  69c —16  ±  74b
Final  conﬁguration  48  ±  6a 501  ±  49c 127  ±  28c,f 11  ±  17  43  ±  90c —28  ±  92c
BiV  reoperation
Baseline  =  standard  BiV  45  ±  8  554  ±  48  186  ±  25  48  ±  33  137  ±  116  73  ±  117
Final  conﬁguration  49  ±  8  530  ±  56  155  ±  22f 15  ±  22  128  ±  157  66  ±  162
DC-LLW
(ms)
OL-LLW
(ms)
LSWMD
(ms)
MVRS/LAS
(%)
TDS  (ms)  LVET  (ms)  LPEI/LVET
All  patients
Baseline  48  ±  81  —19  ±  80  107  ±  91  25  ±  18  455  ±  53  301  ±  49  0.53  ±  0.19
Standard  BiV  44  ±  88  —23  ±  86  90  ±  80  22  ±  18  439  ±  42c 281  ±  40c 0.58  ±  0.18a
Final  conﬁguration  30  ±  86d —39  ±  80a 85  ±  81  19  ±  17c,e 431  ±  42c,d 297  ±  39f 0.46  ±  0.13c,f
First  implantation
Baseline  70  ±  72  13  ±  61  88  ±  77  26  ±  16  431  ±  47  296  ±  50  0.48  ±  0.18
Standard  BiV  62  ±  95  —2  ±  94  94  ±  80  22  ±  17  428  ±  32  270  ±  41c 0.61  ±  0.20c
Final  conﬁguration  45  ±  94d —27  ±  91b 82  ±  57  17  ±  15b,d 422  ±  39  289  ±  40f 0.47  ±  0.14f
Upgrade  from  DDD  pacemaker
Baseline  24  ±  88  —60  ±  85  129  ±  101  18  ±  18  477  ±  50  307  ±  51  0.58  ±  0.20
Standard  BiV  24  ±  79  —47  ±  70  69  ±  58b 15  ±  16  433  ±  37c 288  ±  32a 0.52  ±  0.16
Final  conﬁguration  3  ±  80d —65  ±  70  74  ±  75b 15  ±  15  428  ±  40c 301  ±  30e 0.43  ±  0.11c,f
BiV  reoperation
Baseline  =  standard  BiV  27  ±  78  —35  ±  82  127  ±  110  38  ±  18  490  ±  44  303  ±  43  0.63  ±  0.13
Final  conﬁguration  45  ±  46  —17  ±  43  123  ±  145  31  ±  21  468  ±  37  313  ±  45  0.51  ±  0.14f
BiV: biventricular; DC-LLW: diastolic contraction of the left ventricular lateral wall; DC-Sept: diastolic contraction of the septum;
DDD: dual-chamber; IVMD: interventricular mechanical delay; LAS: left atrial surface; LPEI: left pre-ejection interval; LSWMD:
lateral-to-septal wall motion delay; LV: left ventricular; LVET: left ventricular ejection time; LVFT: left ventricular ﬁlling time; MVRS:
mitral valve regurgitation surface; ND: not determined (right pre-ejection interval not measured); OL-LLW: overlap of left lateral wall
contraction beyond opening of mitral valve; OL-Sept: overlap of septal contraction beyond opening of mitral valve; RV: right ventricular;
TDS: total duration of systole.
a P < 0.05 vs baseline.
b P < 0.01 vs baseline.
c P < 0.001 vs baseline.
d P < 0.05, ﬁnal conﬁguration vs standard BiV.
e P < 0.01, ﬁnal conﬁguration vs standard BiV.
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V  lead  and/or  adding  a  second  RV  lead  was  technically  not
ossible.  In  the  76  patients  in  whom  the  procedure  was  con-
inued  to  optimized  biventricular  or  triple-site  ventricular
timulation,  LPEI  was  shortened  by  ≥10  ms  compared  with
tandard  biventricular  stimulation  in  61  (80%).
Table  3  presents  the  echocardiographical  variables
ecorded  at  baseline,  during  standard  biventricular  pac-
ng  and  during  the  ﬁnal  (biventricular  or  triple-site)  pacing
d
P
P
4onﬁguration.  In  the  overall  population,  standard  biventric-
lar  pacing  improved  septal  contraction,  as  evidenced  by  a
ecrease  in  diastolic  contraction  and  overlap,  and  shortened
he  total  duration  of  systole  compared  with  baseline,  not  by
ecreasing  LPEI  (158  ±  36  ms  vs  154  ±  40  ms,  respectively;
 =  0.32),  but  by  shortening  LVET  (281  ±  40  ms  vs  301  ±  49  ms;
 <  0.001).  LV  ﬁlling  was  not  changed  (LVFT/RR  44  ±  8%  vs
3  ±  8%;  P =  0.14).
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Compared  with  standard  biventricular  pacing,  the  ﬁnal
optimized  pacing  conﬁguration  improved  global  intraven-
tricular  synchrony  (decreasing  LPEI  from  158  ±  36  ms  to
134  ±  29  ms;  P  <  0.001),  LV  systolic  efﬁciency  (decreasing
LPEI/LVET  from  0.58  ±  0.18  to  0.46  ±  0.13;  P <  0.001)  and  LV
ﬁlling  (LVFT/RR  increased  from  44  ±  8%  to  47  ±  7%;  P  <  0.001)
and  decreased  mitral  valve  regurgitation  (ﬁnal  MVRS/LAS
22  ±  18%  vs  19  ±  17%;  P  <  0.01).
Modiﬁcations  of  QRS  and  dyssynchrony  variables  var-
ied  according  to  patient  subgroups.  Patients  undergoing  a
ﬁrst  CRT  implantation  had  no  change  in  QRS  width  (from
141  ±  31  ms  at  baseline  to  142  ±  20  ms;  P  =  0.95).  In  these
patients,  standard  biventricular  pacing  was  deleterious  to
both  LPEI  (from  135  ±  36  ms  at  baseline  to  158  ±  34  ms;
P  <  0.001)  and  LPEI/LVET,  without  any  effect  on  LV  ﬁlling
(Table  3).  Final  pacing  conﬁguration  modiﬁed  these  changes
in  LPEI  and  LPEI/LVET  to  values  similar  to  those  at  baseline,
additionally  improving  LV  ﬁlling,  with  an  increase  in  LVFT/RR
from  42  ±  7%  to  45  ±  7%  (P  <  0.001),  without  deteriorating
systolic  variables.
On  the  other  hand,  patients  upgraded  from  a  DDD  pace-
maker  had  a  wider  QRS  at  baseline  which  was  narrowed
by  the  optimization  procedure  (Table  2).  In  this  group,
standard  biventricular  pacing  immediately  decreased  LPEI
from  170  ±  36  ms  to  146  ±  37  ms  (P  <  0.001)  by  improving  sep-
tal  contraction  (Table  3).  Final  pacing  stimulation  further
improved  global  intraventricular  dyssynchrony  (ﬁnal  LPEI
of  127  ±  28  ms;  P  <  0.001  compared  with  baseline  and  with
standard  biventricular  pacing);  it  also  improved  LV  systolic
efﬁciency  (ﬁnal  LPEI/LVET  0.43  ±  0.11;  P  <  0.001  compared
with  baseline  and  with  standard  biventricular  pacing)  and
LV  ﬁlling  (ﬁnal  LVFT/RR  48  ±  6%  compared  with  44  ±  9%  at
baseline;  P  <  0.05).
Finally,  non-responder  biventricular  patients  upgraded  to
triple-site  pacing  exhibited  a  trend  towards  a  shortening  of
QRS  duration  and  rightward  axis  deviation,  with  a  signiﬁ-
cant  increase  in  LVEF  (Table  2).  Similar  to  patients  upgraded
from  a  DDD  pacemaker,  both  their  LPEI  (from  186  ±  25  ms
to  155  ±  22  ms;  P  <  0.001)  and  LPEI/LVET  (from  0.63  ±  0.13
to  0.51  ±  0.14;  P  <  0.001)  decreased  with  the  ﬁnal  pacing
conﬁguration.
Discussion
To  our  knowledge,  this  study  is  the  ﬁrst  to  show  that
intraoperative  guidance  of  implantation  of  RV  lead(s)
based  on  echocardiographical  assessment  of  dyssynchrony
is  technically  feasible,  safe  and  associated  with  acute
haemodynamic  beneﬁt.  The  study  also  demonstrates  that
the  position  and  number  of  RV  leads  induce  substantial
changes  in  LV  mechanical  dyssynchrony  variables,  which
may  have  a  positive  impact  on  global  intraventricular
synchrony  compared  with  standard  ‘classical’  biventricular
implantation.
A recent  consensus  paper  has  described  actual  standard
CRT  procedure  [11].  After  placement  of  the  RV  lead,  it  is
pointed  that  optimal  placement  of  the  LV  lead  sometimes
remains  a  challenge  limited  by  coronary  sinus  anatomy.
Alternative  non-anatomical  LV  lead  placement  strategies
have  been  investigated,  such  as  targeting  sites  with  max-
imal  electrical  delay  or  maximal  mechanical  dyssynchrony
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12—14]. Both  strategies  are  limited  by  the  difﬁculty  in
dentifying  the  region  of  interest  and  getting  to  it.  In  a  recent
rospective  study  [13],  patients  were  randomized  to  tar-
eted  LV  placement  at  the  latest  site  of  peak  contraction
dentiﬁed  before  the  implantation  procedure  by  speckle-
racking  radial  strain  imaging  or  to  standard  unguided  LV
lacement.  The  echocardiographical  response  to  CRT  was
etter  when  the  LV  lead  was  placed  at  the  targeted  site
ompared  with  at  adjacent  or  remote  sites,  but  this  was
chieved  in  only  63%  of  patients  in  whom  the  optimal  site
as  known  to  the  operator.
In  the  present  study,  owing  to  limited  LV  lead  position  pos-
ibilities  because  of  coronary  venous  anatomy  constraints,
e  hypothesized  that  optimizing  RV  rather  than  LV  stimula-
ion  would  be  technically  easier.  Although  probably  not  to
he  same  magnitude  as  with  both  RV  and  LV  lead  optimiza-
ion,  we  observed  signiﬁcant  reductions  in  LV  dyssynchrony
ariables  and  immediate  improvement  in  ejection  fraction.
he  procedure  was  guided  by  LPEI  reduction.  This  choice
as  driven  by  the  fact  that,  contrary  to  many  other  varia-
les  of  dyssynchrony,  LPEI  is  simple  to  measure,  with  good
nterobserver  and  intraobserver  reproducibility,  and  might
e  predictive  of  CRT  response  [10]. Prolongation  of  LPEI  is
ssociated  with  abnormal  impulse  propagation  and  results  in
ncreased  duration  of  ventricular  systole.  In  our  study,  when
eduction  was  obtained,  signiﬁcant  improvements  in  other
yssynchrony  variables  were  observed,  suggesting  a  key  role
or  this  variable  in  dyssynchrony  assessment,  which  deserves
urther  evaluation.  Our  strategy  resulted  in  decreasing  LPEI
ith  the  ﬁnal  pacing  conﬁguration  compared  with  both  base-
ine  and  standard  biventricular  pacing,  even  in  the  subgroup
f  patients  reoperated  on  after  a  ﬁrst  unsuccessful  CRT
ystem;  it  was  associated  with  improved  LV  ﬁlling,  inter-
entricular  synchrony  and  septal  contraction,  conﬁrming  a
lose  interplay  between  the  various  forms  of  dyssynchrony.
ifferences  in  the  resynchronization  process  between  ﬁrst
mplantation  and  upgraded  patients  also  suggest  that  the
echanism  of  mechanical  dyssynchrony  is  deﬁnitely  differ-
nt  between  these  subgroups.
Importantly,  standard  biventricular  stimulation  was  sat-
sfactory  in  only  17%  of  patients  in  this  study.  Optimized
iventricular  (after  testing  different  RV  lead  positions)
r  triple-site  ventricular  pacing  (by  adding  a  second  RV
ead)  acutely  improved  patients  who  would  otherwise  have
een  mechanically  unchanged,  deteriorated  or  suboptimally
mproved  if  standard  unguided  implantation  had  been  per-
ormed.  In  these  patients,  our  tailored  procedure  has  led
o  an  LPEI  shortening  by  ≥10  ms  compared  with  standard
iventricular  stimulation  in  80%  of  cases,  with  associated
mprovement  in  other  dyssynchrony  variables  and  mitral
alve  function.
Although  this  study  was  an  acute  experiment  and  did
ot  evaluate  the  long-term  haemodynamic  beneﬁt  of  this
ptimized  mechanically  driven  procedure,  evidence  of  non-
ptimal  CRT  provided  by  standard  biventricular  stimulation
aises  two  questions:  can  we  really  consider  standard
iventricular  stimulation  as  true  cardiac  resynchroniza-
ion  therapy  and  in  how  many  non-responders  to  ‘classical
RT’  is  treatment  not  correct  and  therapy  not  delivered?
he  answers  are  unknown  as  mechanical  resynchronization
as  never  been  assessed  after  implantation  in  long-term
tudies.
176  
Figure 3. Chest radiograph showing triple-site pacing system. An
apical right ventricular (RV) lead (RVa) is connected to the RV chan-
nel of the pacemaker and a septal RV lead (RVs) and left ventricular
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dictors of response to CRT (PROSPECT) trial. Circulation
2008;117:2608—16.LV) lead are connected through a Y-adapter to the LV channel.
Recent  studies  have  focused  on  the  impact  of  the  num-
er  and  position  of  RV  lead(s)  on  CRT  response.  The
hoice  of  a  septal  or  an  apical  RV  lead  position  has  not
een  shown  to  inﬂuence  echocardiographical  and  clini-
al  outcomes  [15],  but  its  anatomical  relationship  with
he  LV  lead  —  namely,  a  great  interlead  distance  —  probably
oes  inﬂuence  haemodynamic  response,  especially  in  non-
schaemic  cardiomyopathies  [16].  Triple-site  ventricular
acing  with  two  RV  leads  has  been  shown  to  acutely  improve
entricular  contractility  in  31%  of  patients  compared  with
iventricular  pacing  [17]  and,  as  in  our  study,  could  be  per-
ormed  without  prolonging  excessively  the  procedural  time.
n  the  individual  patient,  the  optimal  pacing  conﬁguration  is
ifﬁcult,  if  not  impossible,  to  determine  before  the  implan-
ation  procedure,  owing  to  different  patterns  and  extent
f  mechanical  dyssynchrony,  even  in  patients  with  typical
eft-bundle  branch  block.  Our  study  suggests  feasibility  and
afety  of  intraprocedural  optimization  of  the  location  and
umber  of  RV  pacing  sites  and  its  efﬁcacy  in  acutely  cor-
ecting  mechanical  dyssynchrony.
tudy limitations
his  pilot  study  was  not  randomized  and  was  limited  to  an
cute  evaluation  of  an  implantation  strategy.  Importantly,
chocardiography  was  not  used  for  the  purposes  of  patient
election  or  prediction  of  clinical  response  to  CRT,  but  as
 mechanistic  tool.  LPEI  was  not  improved  in  all  patients
nd  better  selection  of  patients  in  whom  this  strategy  might
e  useful  is  needed.  Routine  implementation  of  this  strat-
gy  must  also  be  weighed  against  the  potential  risks  of  this
ore  complex  procedure.  We  cannot  determine  the  extra
ime  needed  for  lead  implantation  in  the  absence  of  a  con-
rol  group,  but  we  limited  the  total  procedural  time  to
 hours,  which  seemed  reasonable  for  CRT  implantation.  To
ur  knowledge  no  infection  occurred  in  the  ﬁrst  6  months.
inally,  randomized  controlled  trials  are  needed  to  assess
he  long-term  clinical  impact  of  this  strategy.
[G.  Moubarak  et  al.
onclusions
ntraoperative  echocardiography-guided  RV  lead  placement
uring  CRT  implantation  (ﬁrst  implantation  or  upgrading
rocedure)  is  feasible  and  acutely  improves  LV  synchrony
ompared  with  standard  unguided  biventricular  stimula-
ion.  Most  optimized  conﬁgurations  will  require  two  RV
eads,  resulting  in  triple-site  ventricular  pacing.  Long-term
ontrolled  evaluation  is  needed  to  determine  if  such  a
echanically  guided  implantation  procedure  is  associated
ith  better  outcome.
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